Abstract
Traditionally known as the individually tailored “one size fits all” health care helping individual patients, personalised medicine over the last few decades has slowly been transforming to “genetically-based” health care and pharmacogenetics, thereby luring the light of bioethics.
Although personalised medicine triggers different ethical levels and provokes main bioethical principles, the authors in the article examine two principles: the one of justice, and the other of autonomy, concluding with remarks on trembling equity and limitation in personal autonomy.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The first modern use of the term goes back to 1971, becoming more present during 1990s, and by 2009 “most papers no longer define the term”, indicating general understanding in scientific community (Schleidgen et al. 2013).
- 2.
See the cover of the TIME magazine of the January 15, 2001 issue (Hedgecoe 2004).
- 3.
Ethical, legal and social implication.
References
Annas G (2014) Personalized medicine or public health? Bioethics, human rights, and choice. Rev Port Saude Publica 32(2):158–163
Callahan D (2015) Daniel Callahan on communitarian bioethics. BioEdge October 28. http://www.bioedge.org/bioethics/interview-with-daniel-callahan/11626. Accessed 30 Sep 2016 (interview by Xavier Symons)
Chatterjee B, Pancholi J (2011) Prakriti-based medicine: a step toward personalized medicine. Int Q J Res Ayurveda AYU 32(2):141–146
Engelhardt TH (1996) The foundations of bioethics. Oxford University Press, New York/Oxford, p 3
Evans K (2009) Personalized medicine in psychiatry: ethical challenges and opportunities. Dialogues Clin Neurosci 11(4):429
Food and Drug Administration (2013) Paving the way for personalized medicine: FDA’s role in a new era of medical product development. http://www.fda.gov/. Accessed 26 June 2016
Hedgecoe A (2004) The politics of personalised medicine: pharmacogenetics in the clinic. Cambridge University Press, Oxford. (publisher book excerpt)
Lewis J, Lipworth W, Kerridge I (2014) Ethics, evidence and economics in the pursuit of personalized medicine. J Pers Med 4(2):137–146
Muzur A, Rinčić I (2015) Između znanja i mudrosti: Van Rensselaer Potter i njegovo mjesto u povijesti bioetike (Between knowledge and wisdom: Van Rensselaer Potter and his place in the history of bioethics). Pergamena, Zagreb
Pavelić K et al (2014) Do we understand the personalized medicine paradigm? EMBO Rep (16):133–136. https://doi.org/10.15252/embr.201439609
Personalised Medicine Coalition (2011) The case for personalised medicine, 3rd edn
Rinčić I, Muzur A (2012) Fritz Jahr i rađanje europske bioetike (Fritz Jahr and the emerging of European bioethics). Pergamena, Zagreb
Schleidgen S et al (2013) What is personalised medicine: sharpening a vague term based on a systematic literature review. BMC Biomed Ethics (14):55
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Muzur, A., Rinčić, I. (2019). (Bio)ethical Aspects of Personalised Medicine: Revealing an “Inconvenient Truth”?. In: Bodiroga-Vukobrat, N., Rukavina, D., Pavelić, K., Sander, G.G. (eds) Personalized Medicine in Healthcare Systems. Europeanization and Globalization, vol 5. Springer, Cham. https://doi.org/10.1007/978-3-030-16465-2_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-16465-2_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16464-5
Online ISBN: 978-3-030-16465-2
eBook Packages: Law and CriminologyLaw and Criminology (R0)